Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Main menu

  • Pfizer Products
  • Patient Materials
  • Primary Care
  • News
Pfizer Home

Support & Services

  • Healthcare Professional Downloadable Resources
  • Healthcare Professional Resources
  • Healthcare Professional Resources
  • Patient Resources
  • Patient Support
  • Xalkori® Healthcare Professional Resources

Search form

Healthcare Professional Resources

ZIRABEV® (bevacizumab) has the same dosing as the reference Bevacizumab1

Click here to download the ZIRABEV® dosing guidelines

Click here to download the ZIRABEV® patient booklet

Click here to download the "What do I need to know about Biosimilar Medicines patient" booklet

 

Click here for ZIRABEV® Prescribing Information   ➤

 

Reference:

1. ZIRABEV® (Bevacizumab) Summary of Product Characteristics

 

 

 

PP-BIO-IRL-0130. Preparation Date: April 2021.
Pfizer Home

Support & Services

  • Healthcare Professional Downloadable Resources
  • Healthcare Professional Resources
  • Healthcare Professional Resources
  • Patient Resources
  • Patient Support
  • Xalkori® Healthcare Professional Resources
View Summary of Product Characteristics   ➤

Footer menu

  • Report Adverse Events
  • Terms of Use
  • Privacy Notice
  • Contact Us
  • Site map

Copyright footer block

Copyright © 2016-2022 Pfizer Healthcare Ireland. All rights reserved.

Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002

For medicines information online, please visit www.medicines.ie

PP-UNP-IRL-0010  Date of Preparation: February 2022

 

Dialog

Welcome to

The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.

Access Website
Not a healthcare professional in Ireland? Click here